New-generation radiopaque substances have been developed on the basis of lanthanum orthotantalate (LOT) or yttrium orthotantalate (YOT).

  APPLICATIONS: endoscopic retrograde cholangiopancreatography, intraoperative transfistula cholecystocholangiography, and endobiliary interventional radiology.

    ADVANTAGES
• High image contrast.
• The developed substances are not toxic and exert no negative effect on mucous tunic.

• They are quickly excreted from the organism (in 1or 2 days).

• The radiation dose received by patients and medical personnel is reduced.

• More types of diseases can be diagnosed.

 The development is covered by patents of the Russian Federation.